| CEO: | Peter Collins |
| Executive Chairman: | Jan Groen |
| Senior Independent Director: | Klaas de Boer |
| Non-Executive Dir: | Benjamin Hart , Kim Oreskovic |
| Address: | 10 Nugent Road, Surrey Research Park, Guildford, Surrey, United Kingdom, GU2 7AF |
| Phone: | +44 (0)1483 343434 |
| Website: | http://cellbxhealth.com |
| Sector: | Support(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0034330679 |
| Currency | UK Pounds |
| Share Price | 1.10p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 6.75p |
| 52 Week Low | 0.82p |
| Volume | 1,052,981 |
| Shares Issued | 1,139.40m |
| Market Cap | £12.53m |
| Beta | 0.02 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:25 | 50,000 @ 1.11p |
| 14:22 | 1,250 @ 1.11p |
| 11:52 | 100,000 @ 1.18p |
| 11:50 | 168,067 @ 1.19p |
| 11:35 | 1,276 @ 1.20p |
You are here: research